Core C: Experimental Models
Core C: Experimental Models
批准号:
10263186
负责人:
MICHAEL E. BERENS
金额:
$25.11万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-14 至 2026-06-30
关键词:
Animal ModelAstrocytesBehaviorBloodBrain NeoplasmsCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCharacteristicsClinicClinical DataCollectionDNADataDatabasesDominant-Negative MutationElectroporationEngineeringEventExperimental ModelsFTH1 geneFemaleFour Core GenotypesFreezingGenerationsGenesGeneticGenetically Engineered MouseGenomicsGlioblastomaGliomaGoalsGonadal Steroid HormonesGrowthGuidelinesH ferritinHeterogeneityHumanIACUCImplantIndividualInformaticsInfrastructureInstitutionInstitutional Review BoardsIronKaryotype determination procedureKnock-outKnockout MiceLCN2 geneLabelModelingMusNeurofibromatosis 1OrganoidsOutcomeParaffinPathologyPatientsPerformancePloidiesPopulationPre-Clinical ModelPreclinical TestingQuality ControlReporterResearch PersonnelResourcesSecureServicesSex ChromosomesSex DifferencesSpecimenStandardizationTP53 geneTechnologyTestingTestisTissue BanksTissuesTreatment outcomeTumor Cell LineUniversitiesUniversity HospitalsValidationXenograft procedureY Chromosomeautosomebasebiobankcancer imagingcell transformationclinically relevantcost effectivedata sharingexperimental studyhuman subjecthuman tissueimaging platformin uteroin vivoin vivo imagingin vivo two-photon imaginginnovationjunctional adhesion moleculemalemodel developmentmouse modelneoplastic cellpathology imagingpatient derived xenograft modelquality assuranceradiological imagingresponsesexsry Genestranscriptome sequencingtranscriptomicstumor microenvironmenttwo photon microscopy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Experimental Models Core is responsible for curation, tracking, quality control, and distribution of all
glioblastoma (GBM) animal models (patient-derived xenograft (PDX) models, PDX-derived organoids, syngeneic
mouse and genetically engineered mice) for experimental studies in all Projects and biospecimens from humans
for validation across multiple institutions. The Core will also be responsible for the generation of organoids from
these models, for two-photon in vivo imaging of tumors in mice, and for single cell and spatial transcriptomics as
technology resources for the P01. A suite of >180 PDX GBM models and >5 syngeneic mouse models with
genomic profiling (DNA, RNA sequencing) are available for hypothesis testing by the projects. Human specimens
to confirm findings from mouse models will help validate sex differences, albeit the innate heterogeneity across
human patients compared to mouse models is a caveat. The core strengthens the projects and the P01 by
coordinating the distribution of models for experimental studies in which the sex of the tumor cells are
characterized via sex gene-specific PCR and sex chromosome karyotyping. The goals of the Experimental
Models Core will be accomplished through the following specific aims: 1) To create, organize, and maintain
infrastructure, then deploy syngeneic and genetically engineered mouse glioma models, patient-derived
xenograft GBM models, short-term GBM cultures and organoids, providing high-quality, scientifically relevant
biospecimens to P01 investigators using standardized collection, quality control, storage/tracking and distribution
under approved IACUC guidelines, and 2) To make high-quality, scientifically-relevant clinical biospecimens
available to the P01 investigators through continued efforts and innovations in standardized collection, quality
control (including centralized neuro pathology review), storage/tracking and distribution under proper human
subject (OHRP) regulatory guidelines using secure, readily accessible databases. A decided benefit of the
Experimental Models Core is the coordination and visibility of shared use of models across all Projects, with
shared quality control, batch (or passage) effects, growth characteristics, genomic profiling, and cross-Project
data sharing from the experimental outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10488225
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10696195
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10306303
-
项目类别:
-
资助金额:$13.09万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10488209
-
项目类别:
-
资助金额:$13.11万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10696184
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10306306
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10463734
-
项目类别:
-
资助金额:$54.89万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10023719
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10653109
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Credentialing murine models for glioblastoma preclinical drug development
-
批准号:9986359
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2016
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8323848
-
项目类别:
-
资助金额:$88.71万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8663201
-
项目类别:
-
资助金额:$78.85万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8464685
-
项目类别:
-
资助金额:$78.3万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8850252
-
项目类别:
-
资助金额:$80.56万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:9057986
-
项目类别:
-
资助金额:$79.42万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
The Southwest Comprehensive Center for Drug Discovery and Development
-
批准号:7942802
-
项目类别:
-
资助金额:$270.05万
-
财政年份:2009
-
负责人:MICHAEL E. BERENS
-
依托单位:
Arrested migration fosters apoptosis of glioma cells
-
批准号:6805713
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2003
-
负责人:MICHAEL E. BERENS
-
依托单位:
Arrested migration fosters apoptosis of glioma cells
-
批准号:6582331
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2003
-
负责人:MICHAEL E. BERENS
-
依托单位:
Genetic Pathways of Glioma Invasion
-
批准号:6530031
-
项目类别:
-
资助金额:$44.77万
-
财政年份:2001
-
负责人:MICHAEL E. BERENS
-
依托单位:
Genetic Pathways of Glioma Invasion
-
批准号:6653804
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2001
-
负责人:MICHAEL E. BERENS
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: